Palisade Asia-Pacific Pty Limited Company Profile

13:47 EDT 18th June 2018 | BioPortfolio

Palisade Corporation is committed to developing the world’s most robust, innovative, and comprehensive risk, decision, and data analysis software and training services.
Founded in 1984, Palisade’s first decision analysis programme was called PRISM. PRISM gave desktop computer users, for the first time ever, the ability to quantify risk by running Monte Carlo simulations, a number-crunching exercise previously only available on mainframes. It was soon succeeded by @RISK, which added Monte Carlo simulation to spreadsheets. @RISK quickly became the company’s flagship product and the world’s leading risk analysis tool.
Building on the success of @RISK, Palisade has developed other programmes to meet the growing professional demand for technically refined decision analysis tools. Nearly all Palisade products “add-in” to Microsoft Excel, making their powerful technology accessible to users in many industries.
These innovations, along with comprehensive training and consulting services, keep Palisade at the forefront of risk and decision analysis solution providers.


Suite 101, Level 18 Cliff Street
Milsons Point
New South Wales


Phone: 61 2 9929 9799
Fax: 61 2 9954 3882

News Articles [1085 Associated News Articles listed on BioPortfolio]

BRIEF — Aimmune trading higher on full PALISADE publication

US biotech Aimmune Therapeutics has published full results from its 554-patient Phase III PALISADE trial…

Mavenlink Expands to Asia-Pacific With New Office in Melbourne

The new Melbourneoffice will serve Mavenlink's fast-growing base of clients in Asia-Pacific, and act as the central sales and services hub for the Read more...

Genedrive to premiere Hepatitis C test at Asia-Pacific medical exhibition

The AIM-listed diagnostics company said the kit would make its debut at the MEDLAB Asia Pacific Exhibition & Congress in Singapore

Asia-Pacific COPD Therapeutics Markets 2017-2023: Marketed Products, Pipeline Analysis, ...

Asia-Pacific(APAC) chronic obstructive pulmonary disease (COPD) market is forecast to grow from around $3.8 billionin 2016 to over $6.5 billionin 2023, at Read more...

ASIA PACIFIC MEDICAL LIFTING SLINGS MARKET FORECAST 20182026 [Report Updated: 15012018] Prices from USD $1250

KEY FINDINGSThe Asia Pacific medical lifting slings market is anticipated to hit $ 310.5 million by 2026. The growth of the market is projected at a CAGR of 11.71% throughout the estimated years. Rise...

Aimmune Therapeutics (AIMT) Phase 3 PALISADE Trial Top - Slideshow

Hyundai Large SUV Could Be Called “Palisade”

Kia Telluride's brother should be revealed early next year.

BoehmiteAsia Pacific Market Status and Trend Report 20132023 [Report Updated: 12022018] Prices from USD $3480

Report SummaryBoehmiteAsia Pacific Market Status and Trend Report 20132023 offers a comprehensive analysis on Boehmite industry, standing on the readers' perspective, delivering detailed market data a...

Drugs and Medications [110 Associated Drugs and Medications listed on BioPortfolio]

Pacific garden [Carroll Company]

pacific garden Antimicrobial Foam Soap Pacific Citrus™, Mandarin

Georgia pacific [Carroll Company]

Georgia-Pacific Gel Hand SanitizerAloe, Clear Green

Pacific garden [Carroll Company]

pacific garden Foam Hand Sanitizer Fragrance Free, Dye Free

Pacific garden [Carroll Company]

pacific garden Antimicrobial Foam Soap Fragrance Free, Dye Free

Enmotion [Carroll Company]

enMotion Antimicrobial Foam Soap, w/Moisturizers Fragrance Free, Dye Free

PubMed Articles [486 Associated PubMed Articles listed on BioPortfolio]

Asia Pacific Clinical Nutrition Society Award for 2018: Professor Chunming Chen.

Literature review of the epidemiology of influenza B disease in 15 countries in the Asia-Pacific region.

Influenza control strategies focus on the use of trivalent influenza vaccines containing two influenza A virus subtypes and one of the two circulating influenza type B lineages (Yamagata or Victoria)....

Practice Patterns for Chronic Respiratory Diseases in the Asia-Pacific Region: A Cross-Sectional Observational Study.

Allergic rhinitis (AR), asthma, chronic obstructive pulmonary disease (COPD), and rhinosinusitis are common and little studied in the Asia-Pacific region.

Consensus on best practice standards for Fracture Liaison Service in the Asia-Pacific region.

The Fracture Liaison Service (FLS) Consensus Meeting endorsed by the International Osteoporosis Foundation (IOF), Asian Federation of Osteoporosis Societies (AFOS), and Asia Pacific Osteoporosis Found...

Paliperidone Palmitate Improves and Maintains Functioning in Asia-Pacific Patients with Schizophrenia.

Post hoc analyses (two single-arm studies) were conducted to determine the impact of once-monthly injection of paliperidone palmitate on functioning in adult patients with schizophrenia in the Asia-Pa...

Clinical Trials [324 Associated Clinical Trials listed on BioPortfolio]

PROUD Study: A Prospective Study on the Usage Patterns of Doripenem in the Asia Pacific Region

The purpose of this study is to understand the utilization patterns of doripenem in Asia Pacific, including the profile of the patients treated with carbapenems.

Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and During Acute Exacerbations of the Disease, in Asia Pacific

Since the infectious aetiology of AECOPD has been suggested to vary according to geographical region, the primary purpose of this study (which will be conducted in several countries in Asi...

Determining the Prevalence of HIV-Related Neurological Disorders in the Asia Pacific

This study will determine the prevalence of HIV-related neurological disorders in the countries of the Asia-Pacific Region.

The RECORD Asia-Pacific Atrial Fibrillation Registry

The Primary objective of this registry is to assess the control of Atrial Fibrillation (AF) over one year in patients attending clinical or specialized practices. The Secondary objectives...

Remission in Rheumatoid Arthritis in the Asian-Pacific Region

This study is the multi-center, open and cross-sectional study of RA remission in Asia Pacific region. The objectives is to explore remission rate of RA patients in different countries in ...

Companies [787 Associated Companies listed on BioPortfolio]

Palisade Asia-Pacific Pty Limited

Palisade Corporation is committed to developing the world’s most robust, innovative, and comprehensive risk, decision, and data analysis software and training services. Founded in 1984, Palisade’s...

Australian Medtech Services

Australian Medtech Services (AMS) supports early and late-stage medical technology companies focused on commercialization within the Asia Pacific region. As a fully integrated Asi...

The Asia Foundation

The Asia Foundation is a nonprofit, non-governmental organization committed to the development of a peaceful, prosperous, just, and open Asia-Pacific region. The Foundation suppor...

Columbia Asia

Columbia Asia, part of Seattle-based Columbia Pacific, has 19 facilities across India, Malaysia, Vietnam and Indonesia, and plans for 15 new hospitals by the end of 2011.

Palisade Systems, Inc.

More Information about "Palisade Asia-Pacific Pty Limited" on BioPortfolio

We have published hundreds of Palisade Asia-Pacific Pty Limited news stories on BioPortfolio along with dozens of Palisade Asia-Pacific Pty Limited Clinical Trials and PubMed Articles about Palisade Asia-Pacific Pty Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Palisade Asia-Pacific Pty Limited Companies in our database. You can also find out about relevant Palisade Asia-Pacific Pty Limited Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record